Structure Therapeutics Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported net loss was USD 24.5 million compared to USD 11.88 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
46.75 USD | -1.62% | -10.10% | +14.70% |
Jun. 07 | Structure Therapeutics Closes $547.4 Million Offering | MT |
Jun. 07 | BMO Capital Adjusts Price Target on Structure Therapeutics to $100 From $83, Maintains Outperform Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.70% | 2.22B | |
+15.85% | 121B | |
+18.91% | 112B | |
+4.43% | 22.57B | |
-18.63% | 20.82B | |
-13.76% | 16.3B | |
-16.61% | 16.19B | |
-43.53% | 16.17B | |
+1.75% | 13.17B | |
+28.07% | 11.11B |
- Stock Market
- Equities
- GPCR Stock
- News Structure Therapeutics Inc.
- Structure Therapeutics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023